Latest News

04/14/2021

Boehringer Ingelheim speaker event

What Can We Learn About the Evolving Squamous NSCLC Treatment Landscape

06/11/2020

Updated Patient Assistance Program

Janssen Carepath Patient Support Program

06/11/2020

NOVARTIS drug ADAKVEO receives new J-code effective 7/1/2020

Novartis is pleased to announce that for dates of service on or after July 1, 2020, the Centers for Medicare and Medicaid Services (CMS) has issued a product-specific J-code: J0791 for injection, crizanlizumab-tmca, 5 mg. The updated billing unit is 5 mg.

09/24/2007

NPPES and the NPI Registry

Many of you have noted the recent instability of NPPES and the NPI Registry. CMS has begun implementing changes that should eliminate the instability. We expect that these changes will be completed next week.

News & Events